Ovidiu Bălăcescu

3.3k total citations · 1 hit paper
113 papers, 2.4k citations indexed

About

Ovidiu Bălăcescu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ovidiu Bălăcescu has authored 113 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 47 papers in Oncology and 35 papers in Cancer Research. Recurrent topics in Ovidiu Bălăcescu's work include MicroRNA in disease regulation (18 papers), Circular RNAs in diseases (13 papers) and Cancer Cells and Metastasis (12 papers). Ovidiu Bălăcescu is often cited by papers focused on MicroRNA in disease regulation (18 papers), Circular RNAs in diseases (13 papers) and Cancer Cells and Metastasis (12 papers). Ovidiu Bălăcescu collaborates with scholars based in Romania, United States and Sweden. Ovidiu Bălăcescu's co-authors include Ioana Ilie, Daniel Cruceriu, Alexandru Irimie, Oana Baldasici, Loredana Bălăcescu, Claudia Burz, Călin Cainap, Oana Tudoran, Ioana Berindan‐Neagoe and Cosmin Lisencu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Ovidiu Bălăcescu

107 papers receiving 2.4k citations

Hit Papers

The dual role of tumor necrosis factor-alpha (TNF-α) in b... 2020 2026 2022 2024 2020 100 200 300

Peers

Ovidiu Bălăcescu
Ling‐Wen Ding Singapore
Jong Kyu Woo South Korea
Ling Xu China
Diana Gulei Romania
Ling‐Wen Ding Singapore
Ovidiu Bălăcescu
Citations per year, relative to Ovidiu Bălăcescu Ovidiu Bălăcescu (= 1×) peers Ling‐Wen Ding

Countries citing papers authored by Ovidiu Bălăcescu

Since Specialization
Citations

This map shows the geographic impact of Ovidiu Bălăcescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ovidiu Bălăcescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ovidiu Bălăcescu more than expected).

Fields of papers citing papers by Ovidiu Bălăcescu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ovidiu Bălăcescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ovidiu Bălăcescu. The network helps show where Ovidiu Bălăcescu may publish in the future.

Co-authorship network of co-authors of Ovidiu Bălăcescu

This figure shows the co-authorship network connecting the top 25 collaborators of Ovidiu Bălăcescu. A scholar is included among the top collaborators of Ovidiu Bălăcescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ovidiu Bălăcescu. Ovidiu Bălăcescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fetică, Bogdan, et al.. (2025). FICTION Technique—A Candidate for the Assessment of HER2 Status in Breast Invasive Carcinomas. Medicina. 61(6). 1069–1069.
2.
Vișan, Simona, Olga Şoriţău, Corina Tatomir, et al.. (2023). The Bioactive Properties of Carotenoids from Lipophilic Sea buckthorn Extract (Hippophae rhamnoides L.) in Breast Cancer Cell Lines. Molecules. 28(11). 4486–4486. 13 indexed citations
3.
Baldasici, Oana, Loredana Bălăcescu, Daniel Cruceriu, et al.. (2022). Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients. International Journal of Molecular Sciences. 23(20). 12625–12625. 19 indexed citations
4.
Roman, Andrei, Simona Vișan, Eduard-Alexandru Bonci, et al.. (2022). The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy. Medicina. 58(10). 1494–1494. 5 indexed citations
5.
Cruceriu, Daniel, Oana Baldasici, Loredana Bălăcescu, et al.. (2021). Critical Aspects Concerning the Development of a Pooling Approach for SARS-CoV-2 Diagnosis Using Large-Scale PCR Testing. Viruses. 13(5). 902–902. 5 indexed citations
6.
Cruceriu, Daniel, Oana Baldasici, Ovidiu Bălăcescu, & Ioana Ilie. (2020). The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches. Cellular Oncology. 43(1). 1–18. 349 indexed citations breakdown →
7.
Bălăcescu, Ovidiu, Ramona Dumitrescu, & Cătălin Marian. (2018). MicroRNAs Role in Prostate Cancer. Methods in molecular biology. 1856. 103–117. 17 indexed citations
8.
Bălăcescu, Ovidiu, Loredana Bălăcescu, Simona Vișan, et al.. (2016). Blood Genome-Wide Transcriptional Profiles of HER2 Negative Breast Cancers Patients. Mediators of Inflammation. 2016. 1–12. 5 indexed citations
9.
Braicu, Cornelia, Sonia Selicean, Roxana Cojocneanu, et al.. (2016). Evaluation of cellular and molecular impact of zearalenone and Escherichia coli co-exposure on IPEC-1 cells using microarray technology. BMC Genomics. 17(1). 576–576. 19 indexed citations
10.
Bălăcescu, Loredana, Ovidiu Bălăcescu, & Ioana Berindan‐Neagoe. (2015). The Impact of the Preprocessing Methods in Downstream Analysis of Agilent Microarray Data. SHILAP Revista de lepidopterología. 37(4). 29–37. 1 indexed citations
11.
Tudoran, Oana, Olga Şoriţău, Loredana Bălăcescu, et al.. (2015). Regulation of stem cells-related signaling pathways in response to doxorubicin treatment in Hs578T triple-negative breast cancer cells. Molecular and Cellular Biochemistry. 409(1-2). 163–176. 10 indexed citations
12.
Fetică, Bogdan, et al.. (2014). An alternative and sensitive method based on LCM and Q-PCR for HER2 testing in breast cancer. Cancer Biomarkers. 14(2-3). 129–135. 4 indexed citations
13.
Iuga, Cristina Adela, et al.. (2012). A PROPOSED CURATION PROTOCOL FOR DISCOVERY CANCER POTENTIAL BIOMARKER CANDIDATES. SHILAP Revista de lepidopterología. 81.
14.
Berindan‐Neagoe, Ioana, Cornelia Braicu, Ioan Ştefan Florian, et al.. (2012). Quantitative mRNA expression of genes involved in angiogenesis, coagulation and inflammation in multiforme glioblastoma tumoral tissue versus peritumoral brain tissue: lack of correlation with clinical data. European Cytokine Network. 23(2). 45–55. 17 indexed citations
15.
Samaşcă, Gabriel, et al.. (2012). Soluble CD163 serum levels are elevated and correlated with IL-12 and CXCL10 in patients with long-standing rheumatoid arthritis. Rheumatology International. 33(4). 1031–1037. 19 indexed citations
16.
Ilie, Ioana, Cornelia Braicu, Oana Tudoran, Ovidiu Bălăcescu, & Alexandru Irimie. (2012). Early Apoptosis Signals Induced by a Low Dose of Epigallocatechin 3-Gallate Interfere with Apoptotic and Cell Death Pathways. Journal of Nanoscience and Nanotechnology. 12(3). 2113–2119. 9 indexed citations
17.
Vlad, Mariana, Ovidiu Bălăcescu, Bogdan Fetică, et al.. (2011). Risk Profile in a Sample of Patients with Breast Cancer from the Public Health Perspective. SHILAP Revista de lepidopterología. 2 indexed citations
18.
Vlad, Mariana, Ovidiu Bălăcescu, Loredana Bălăcescu, et al.. (2011). Risk Factors in a Sample of Patients with Advanced Cervical Cancer. SHILAP Revista de lepidopterología. 2 indexed citations
19.
Irimie, Alexandru, Ovidiu Bălăcescu, Claudia Burz, et al.. (2011). Prognostic significance of the serum level of different growth factors and their correlation with estrogen receptors in patients with locally advanced breast cancer. ROMANIAN BIOTECHNOLOGICAL LETTERS. 16(5). 6523–6534. 1 indexed citations
20.
Braicu, Cornelia, Ioana Berindan‐Neagoe, Oana Tudoran, et al.. (2009). In vitro evaluation of the chemoprotective action of flavan-3-ols against deoxynivalenol related toxicity.. Archiva zootechnica. 12(3). 45–55. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026